Avanos Medical (AVNS) Stock Overview
A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
AVNS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Avanos Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.23 |
| 52 Week High | US$21.12 |
| 52 Week Low | US$9.30 |
| Beta | 1.1 |
| 1 Month Change | -1.49% |
| 3 Month Change | 3.79% |
| 1 Year Change | -44.98% |
| 3 Year Change | -57.35% |
| 5 Year Change | -73.15% |
| Change since IPO | -71.75% |
Recent News & Updates
Recent updates
Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up
Oct 05Avanos Medical, Inc.'s (NYSE:AVNS) Revenues Are Not Doing Enough For Some Investors
Aug 06
Avanos Medical: Cheap, But With Caveats
Apr 17Avanos Medical (NYSE:AVNS) Has A Pretty Healthy Balance Sheet
Apr 08Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Jan 30What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?
Dec 18Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking
Oct 25There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Shareholder Returns
| AVNS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.1% | 1.7% | -2.0% |
| 1Y | -45.0% | -0.6% | 12.1% |
Return vs Industry: AVNS underperformed the US Medical Equipment industry which returned -1% over the past year.
Return vs Market: AVNS underperformed the US Market which returned 12.3% over the past year.
Price Volatility
| AVNS volatility | |
|---|---|
| AVNS Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AVNS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AVNS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 2,227 | Dave Pacitti | avanos.com |
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems.
Avanos Medical, Inc. Fundamentals Summary
| AVNS fundamental statistics | |
|---|---|
| Market cap | US$518.96m |
| Earnings (TTM) | -US$468.60m |
| Revenue (TTM) | US$699.90m |
Is AVNS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVNS income statement (TTM) | |
|---|---|
| Revenue | US$699.90m |
| Cost of Revenue | US$334.00m |
| Gross Profit | US$365.90m |
| Other Expenses | US$834.50m |
| Earnings | -US$468.60m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -10.10 |
| Gross Margin | 52.28% |
| Net Profit Margin | -66.95% |
| Debt/Equity Ratio | 13.2% |
How did AVNS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 18:21 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avanos Medical, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ravi Misra | Berenberg |
| Daniel Stauder | Citizens JMP Securities, LLC |
| Kristen Stewart | Deutsche Bank |